Thyrocare Technologies

THYROCARE•

NSE

BSE

SectorHealthcare Services

‌
‌
‌

₹578.65

+₹142.89(32.93%)•Past Year

Loading chart…

Company insights, generated from the most recent coverage.

API Holdings' debt-free status removes balance sheet constraints, enabling aggressive M&A in digital healthcare using cash or Thyrocare shares as currency without leverage covenants.
Read more
Thyrocare EBITDA turned positive in FY26 (+₹62.5 Cr) with margins expanding to 32.19% in Q1 FY27; parent's debt-free status saves ₹150-200 Cr annual interest, fueling further margin growth.
Read more
Complete release of promoter pledge eliminates overhang risk and enhances financial flexibility, potentially supporting valuation multiples.
Read more

‌
‌
‌

In the news

Thyrocare shares rise 3% as Docon sells 9.9% stake for ₹986 crore

Thyrocare Q1 profit jumps 34% to ₹52.19 crore; ICICI Securities targets ₹650

5 Stocks to Buy: Jio Financial, Lenskart Solutions with up to 26% upside

MarketSmith India Recommends Thyrocare, GMR Airports for July 1

Company insights, generated from the most recent coverage.

API Holdings' debt-free status removes balance sheet constraints, enabling aggressive M&A in digital healthcare using cash or Thyrocare shares as currency without leverage covenants.
Read more
Thyrocare EBITDA turned positive in FY26 (+₹62.5 Cr) with margins expanding to 32.19% in Q1 FY27; parent's debt-free status saves ₹150-200 Cr annual interest, fueling further margin growth.
Read more
Complete release of promoter pledge eliminates overhang risk and enhances financial flexibility, potentially supporting valuation multiples.
Read more